Nicholas D Smith Selected Research

Nicholas D Smith Research Topics

Disease

8	Neoplasms (Cancer) 01/2019 - 05/2008
7	Breast Neoplasms (Breast Cancer) 01/2019 - 06/2015
4	Pain (Aches) 02/2011 - 05/2009
4	Insulin Resistance 12/2008 - 01/2003
3	Hyperthyroidism 12/2008 - 06/2002
3	Starvation 12/2008 - 06/2002
2	Prostatic Neoplasms (Prostate Cancer) 03/2012 - 05/2008
2	Neuralgia (Stump Neuralgia) 11/2010 - 05/2009
1	Alcoholic Fatty Liver 01/2021
1	Pruritus (Itching) 01/2021
1	Scotoma (Scintillating Scotoma) 09/2016
1	Glaucoma 12/2015
1	Inflammation (Inflammations) 01/2012
1	Hyperalgesia 02/2011
1	Edema (Dropsy) 02/2011
1	Endotoxemia 07/2009
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 05/2008
1	Hyperglycemia 12/2006
1	Brain Ischemia (Cerebral Ischemia) 07/2005
1	Hyperinsulinism (Hyperinsulinemia) 02/2004
1	Glucose Intolerance 09/2003

Drug/Important Bio-Agent (IBA)

7	Estrogen ReceptorsIBA 01/2019 - 06/2015
6	Tamoxifen FDA LinkGeneric 01/2019 - 06/2015
5	Insulin (Novolin)FDA Link 12/2008 - 06/2002
4	Formaldehyde (Formol)FDA Link 02/2011 - 05/2009
4	Glucose (Dextrose)FDA LinkGeneric 12/2008 - 01/2003
4	PPAR alphaIBA 12/2008 - 06/2002
3	3- (4- (2- (2- chloro- 4- fluorophenyl)- 1- (1H- indazol- 5- yl)but- 1- en- 1- yl)phenyl)acrylic acidIBA 01/2019 - 06/2015
3	4- ((2- cyclobutyl- 1H- imidazo(4,5- b)pyrazin- 1- yl)methyl)- 7,8- difluoroquinolin- 2(1H)- oneIBA 02/2011 - 05/2009
3	KD 5170IBA 12/2008 - 05/2008
3	LipidsIBA 12/2008 - 02/2003
3	pirinixic acidIBA 02/2003 - 06/2002
2	IndazolesIBA 01/2019 - 11/2015
2	Aromatase InhibitorsIBA 01/2018 - 06/2015
2	Estrogen Receptor alphaIBA 01/2018 - 06/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2012 - 02/2011
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2011 - 05/2009
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 02/2011 - 11/2010
2	QuinolonesIBA 11/2010 - 05/2009
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2008 - 01/2003
2	Histone Deacetylase InhibitorsIBA 12/2008 - 05/2008
2	Histones (Histone)IBA 12/2008 - 06/2008
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 02/2004 - 09/2003
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2004 - 06/2002
2	Proteins (Proteins, Gene)FDA Link 02/2003 - 06/2002
1	FXR agonist MET409IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	BenzopyransIBA 01/2018
1	Androgen Antagonists (Antiandrogens)IBA 03/2012
1	apalutamideIBA 03/2012
1	Androgen Receptors (Androgen Receptor)IBA 03/2012
1	EnzymesIBA 01/2012
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2012
1	Celecoxib (Celebrex)FDA Link 02/2011
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 02/2011
1	Pregabalin (Lyrica)FDA Link 02/2011
1	CarrageenanIBA 02/2011
1	phenylbenzoquinoneIBA 02/2011
1	Capsaicin (Zostrix)FDA Link 02/2011
1	Gabapentin (Neurontin)FDA LinkGeneric 02/2011
1	benzimidazoleIBA 11/2010
1	N- (3- chlorophenyl)- N- ((8- fluoro- 2- oxo- 1,2- dihydroquinolin- 4- yl)methyl)- 4- methylthiazole- 5- carboxamideIBA 07/2009
1	Thyroid HormonesIBA 12/2008
1	CarbohydratesIBA 12/2008
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 12/2008
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 12/2008
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2008
1	Vorinostat FDA Link 05/2008
1	Docetaxel (Taxotere)FDA Link 05/2008
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2006
1	Choline (Choline Chloride)IBA 07/2005
1	ProdrugsIBA 07/2005
1	Fish OilsIBA 02/2004
1	Protein Isoforms (Isoforms)IBA 06/2002
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 06/2002
1	pyruvate dehydrogenase kinase 4IBA 06/2002
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 06/2002

Therapy/Procedure

3	Therapeutics 01/2018 - 06/2015
2	Telescopes 09/2016 - 12/2015
2	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 12/2008 - 06/2002
1	Castration 03/2012
1	Ligation 02/2011
1	Oral Administration 07/2009
1	Intravenous Administration 07/2005
1	Subcutaneous Injections 06/2002